Tag: Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market

Emtricitabine/Rilpivirine/Tenofovir Alafenamide Market Trends And Drivers Emtricitabine/Rilpivirine/Tenofovir Alafenamide market size was valued at USD 2.3 Billion in 2022 and is projected to reach USD 4.1 Billion by 2030, growing at a CAGR of 7.6% from 2024 to 2030. The market growth is primarily driven by the increasing prevalence of HIV infections worldwide, along with rising […]